Michel Hamon Selected Research

5-HT2A Serotonin Receptor (5 HT2A Receptor)

11/2008	Serotonin 5-HT2A receptor involvement and Fos expression at the spinal level in vincristine-induced neuropathy in the rat.
7/2008	Role of spinal serotonin 5-HT2A receptor in 2',3'-dideoxycytidine-induced neuropathic pain in the rat and the mouse.
5/2008	Excess of transmission of the G allele of the -1438A/G polymorphism of the 5-HT2A receptor gene in patients with schizophrenia responsive to antipsychotics.
12/2005	Contribution of 5-HT2 receptor subtypes to sleep-wakefulness and respiratory control, and functional adaptations in knock-out mice lacking 5-HT2A receptors.
3/2005	Negative symptoms of schizophrenia could explain discrepant data on the association between the 5-HT2A receptor gene and response to antipsychotics.
8/2003	Serotonin transporter inhibitors protect against hypoxic pulmonary hypertension.
5/2002	Association of 5-HT(2A) receptor gene polymorphism with major affective disorders: the case of a subgroup of bipolar disorder with low suicide risk.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michel Hamon Research Topics

Disease

21	Neuralgia (Stump Neuralgia) 01/2018 - 12/2002
20	Pain (Aches) 01/2019 - 04/2002
17	Hyperalgesia 01/2018 - 12/2002
10	Mood Disorders (Mood Disorder) 05/2013 - 05/2002
9	Pulmonary Hypertension 09/2012 - 04/2002
6	Inflammation (Inflammations) 01/2019 - 06/2003
6	Hyperplasia 11/2006 - 03/2002
5	Hypersensitivity (Allergy) 10/2014 - 11/2008
5	Depressive Disorder (Melancholia) 05/2014 - 01/2007
5	Hypoxia (Hypoxemia) 09/2012 - 04/2002
5	Schizophrenia (Dementia Praecox) 05/2008 - 03/2004
4	Chronic Pain 10/2014 - 06/2003
4	Bradycardia 04/2011 - 09/2002
4	Familial Primary Pulmonary Hypertension 11/2006 - 03/2002
3	Cognitive Dysfunction 04/2012 - 03/2002
3	Parkinson Disease (Parkinson's Disease) 08/2011 - 08/2009
3	Alcoholism (Alcohol Abuse) 12/2008 - 01/2002
3	Hypothermia 05/2006 - 05/2003
2	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 01/2020
2	Major Depressive Disorder (Major Depressive Disorders) 01/2020 - 01/2009
2	Hypertrophy 09/2012 - 08/2003
2	Memory Disorders (Memory Loss) 08/2011 - 02/2010
2	Parkinsonian Disorders (Parkinsonism) 04/2011 - 08/2009
2	Peripheral Nerve Injuries 02/2010 - 04/2007
2	Diabetic Neuropathies (Diabetic Neuropathy) 02/2007 - 07/2004
2	Sleep Deprivation 08/2006 - 01/2006
2	Vascular Remodeling 05/2005 - 04/2002
2	Alcohol Withdrawal Seizures 05/2004 - 01/2003
2	Alcohol Withdrawal Delirium (Delirium Tremens) 05/2004 - 01/2003
2	Fibrosis (Cirrhosis) 02/2004 - 12/2002
1	Neurobehavioral Manifestations 01/2020
1	Central Nervous System Diseases (CNS Diseases) 12/2019

Drug/Important Bio-Agent (IBA)

24	Serotonin (5 Hydroxytryptamine)IBA 02/2017 - 01/2002
14	Antidepressive Agents (Antidepressants)IBA 01/2020 - 07/2004
8	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 05/2006 - 03/2002
7	5-HT2A Serotonin Receptor (5 HT2A Receptor)IBA 11/2008 - 05/2002
6	Opioid Analgesics (Opioids)IBA 11/2015 - 03/2004
5	Serotonin ReceptorsIBA 01/2020 - 01/2002
5	Brain-Derived Neurotrophic Factor (BDNF)IBA 11/2015 - 02/2008
5	Analgesics (Analgesic Drugs)IBA 01/2014 - 12/2002
5	Fluoxetine (Prozac)FDA LinkGeneric 04/2012 - 08/2003
4	Proteins (Proteins, Gene)FDA Link 12/2019 - 10/2003
4	NeuropeptidesIBA 01/2019 - 04/2002
4	agomelatine (S20098)IBA 01/2018 - 01/2009
4	Neurotransmitter Agents (Neurotransmitter)IBA 09/2013 - 09/2005
4	Tryptamines (Triptans)IBA 09/2012 - 12/2002
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 08/2011 - 04/2006
4	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 04/2011 - 03/2004
4	AutoreceptorsIBA 12/2008 - 05/2003
4	CytokinesIBA 08/2008 - 06/2003
3	Mefloquine (Lariam)FDA LinkGeneric 01/2020 - 12/2016
3	serotonin 7 receptorIBA 11/2012 - 05/2008
3	LigandsIBA 11/2012 - 02/2007
3	Peptides (Polypeptides)IBA 04/2012 - 07/2004
3	proenkephalinIBA 09/2009 - 03/2004
3	Antipsychotic Agents (Antipsychotics)IBA 05/2008 - 03/2005
3	cizolirtineIBA 02/2007 - 07/2003
2	Donepezil (Aricept)FDA LinkGeneric 01/2020 - 01/2020
2	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2020 - 01/2020
2	Morphine (MS Contin)FDA LinkGeneric 01/2019 - 11/2015
2	MelatoninIBA 01/2018 - 05/2013
2	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA 01/2018 - 12/2016
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 11/2015 - 05/2011
2	Phosphotransferases (Kinase)IBA 10/2014 - 03/2004
2	cyclotraxin-BIBA 10/2014 - 06/2012
2	Pharmaceutical PreparationsIBA 05/2014 - 02/2007
2	gamma-Aminobutyric Acid (GABA)IBA 11/2012 - 05/2009
2	Citalopram FDA LinkGeneric 09/2012 - 08/2003
2	3,N- dimethyl- N- (1- methyl- 3- (4- methylpiperidin- 1- yl)propyl)benzenesulfonamideIBA 06/2010 - 02/2009
2	Tetrodotoxin (Tetradotoxin)IBA 02/2010 - 05/2008
2	5-HT1B Serotonin ReceptorIBA 02/2010 - 01/2002
2	EndocannabinoidsIBA 05/2009 - 01/2008
2	phenyl biguanideIBA 05/2009 - 09/2002
2	N- (2- (4- (2- methoxyphenyl)- 1- piperazinyl)ethyl)- N- (2- pyridinyl)cyclohexanecarboxamideIBA 02/2009 - 05/2006
2	Interleukin-6 (Interleukin 6)IBA 08/2008 - 05/2008
2	Calcitonin Gene-Related PeptideIBA 05/2008 - 07/2004
2	Transcription Factors (Transcription Factor)IBA 04/2007 - 04/2007
2	Streptozocin (Streptozotocin)FDA Link 02/2007 - 07/2004
2	CorticosteroneIBA 08/2006 - 01/2006
2	MonocrotalineIBA 05/2006 - 05/2005
2	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 05/2004 - 01/2003
2	Isoproterenol (Isoprenaline)FDA LinkGeneric 02/2004 - 12/2002
2	Adrenergic Receptors (Adrenergic Receptor)IBA 02/2004 - 12/2002
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2020
1	Drug CombinationsIBA 01/2020
1	Connexin 43 (Connexin43)IBA 12/2019
1	PlasticsIBA 12/2019
1	2- amino- 4- (4- fluoronaphth- 1- yl)- 6- isopropylpyrimidineIBA 01/2018
1	Gabapentin (Neurontin)FDA LinkGeneric 01/2018
1	6- chloro- 5- methyl- 1- ((2- (2- methylpyrid- 3- yloxy)pyrid- 5- yl)carbamoyl)indolineIBA 01/2018
1	Serotonin 5-HT2 Receptor AntagonistsIBA 01/2018
1	Serotonin AntagonistsIBA 01/2018
1	MT2 Melatonin ReceptorIBA 01/2018
1	CarrageenanIBA 02/2017
1	Formaldehyde (Formol)FDA Link 02/2017

Therapy/Procedure

8	Ligation 01/2018 - 12/2002
5	Therapeutics 12/2016 - 04/2005
2	Epidural Injections 11/2008 - 07/2008
2	Anesthesia 01/2006 - 07/2004
1	Aftercare (After-Treatment) 01/2019